期刊文献+

间变性大细胞淋巴瘤的形态学及免疫表型与诊断预后的相关性 被引量:9

Anaplastic Large Cell Lymphoma:Correlation of Clinicopathologic Features with Diagnosis and Prognosis
下载PDF
导出
摘要 目的:研究间变性大细胞淋巴瘤(ALCL)的临床病理特点和免疫表型,提高该疾病的早期诊断,并比较ALK+与ALK-在临床表现、治疗和预后的不同点。方法:对原诊断为ALCL的20例病例重新行组织学观察和免疫组织化学染色(ABC法)并复习相关文献。结果:20例中15例属于T/Null细胞表型,结合免疫组化诊断为ALCL,15例ALCL均强烈表达CD30;ALK阳性者9例,ALK的表达与患者性别,免疫分型、组织分型、临床分期无相关性;而与患者年龄及化疗敏感性具有相关性(P<0.05)。其余5例为B细胞表型(CD20强阳性),结合新的淋巴瘤分类标准,被诊断为弥漫性大B细胞淋巴瘤(DLBCL)。结论:间变性大细胞淋巴瘤中具有标志性的大细胞出现CD30、ALK和EMA阳性时,对ALCL的诊断具有重要价值;ALK+ALCL与ALK-ALCL在遗传特征,临床表现及治疗预后的不同,使其作为一种新的病理类型被提出具有合理性。 Objective: To investigate the clinicopathological and immunohistochemical characteristics of anaplastic large cell lymphoma (ALCL) and to compare the differences in clinical manifestation, treatment and prognosis between ALK-positive cases and ALK-negative cases. Methods Histological and immunohistochemical staining methods (ABC method) were used to analyze 20 previously diagnosed cases of ALCL, and the correlated clinical data were reviewed. Results: Fifteen of the 20 cases were T/Null cell type (8 T and 7 Null) and were di- agnosed as ALCL with immunohistochemistry. CD30 was strongly expressed in the 15 cases of ALCL. There were 9 ALK-positive cases. No correlation was found between ALK expression and sex, immunohistochemical type, histological type, or clinical stage. However, a significant correlation was found between ALK expression and age and sensitivity to chemotherapy (P〈0.05). The remaining 5 cases were B cell type, and they were true DLBCL. Conclusion: Our study highlights the importance of histopathological features and the significance of CD30 and ALK in the diagnosis of ALCL. The differences between ALK-positive ALCL and ALK-negative ALCL suggest specific studies on these genes, including differences in clinical manifestation and remission rates after chemotherapy, should be performed.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2008年第15期841-844,共4页 Chinese Journal of Clinical Oncology
基金 天津市科委重大科技攻关项目基金资助(编号:043115211-1)
关键词 淋巴瘤 间变 免疫组织化学 鉴别诊断 Lymphoma Anaplastic lymphoma kinase Immunohistochemistry Differential diagnosis
  • 相关文献

参考文献9

  • 1Delsol G, Ralfkiaer E, Stein H, et al. Anaplastic large cell lymphoma. In: Jaffe ES, Harris NL, Diebold J, et al. World Health Organization classification of tumors. Pathology and genetics of tumors of hematopoietic and lymphoid tlssues[M]. Loyn: IARC Press, 2001. 259-265.
  • 2李晔雄.间变性大细胞淋巴瘤[J].中华放射肿瘤学杂志,2004,13(1):60-63. 被引量:15
  • 3Pulford K, Morris SW,Turturro F. Anaplastic lymphoma kinase proteins in growth control and cancer[J].J Cell Physiol, 2004, 199 (3): 330--358.
  • 4Falini B, Pileri S, Zinzani PL, et al. ALK + lymphoma:clinicopathological findings and outcome[J]. Blood, 1999, 93(8): 2697--2706.
  • 5Shiota M, Nakamura R, Ichinohasama R, et al. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ ALK:a distinct clinicopathologic entity[J]. Blood,1995, 86(5): 1954--1960.
  • 6VassalloJ, Lamant L, Brugieres L, et al. ALK--posidve anaplasfic large cell lymphoma mimicking nodular sclerosis Hodgkin's lymphoma: report of 10 cases[J]. Am J Surg Pathol, 2006, 30(2): 223--229.
  • 7Cataldo KA, Jalal SM, Law ME, et al. Detection of t(2;5)in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin--embedded tissue[J]. AmJ Surg Pathol, 1999, 23(11): 1386-1392.
  • 8DuysterJ, Bai RY, Morris SW. Translocations involving anaplastic lymphoma kinase(ALK)[J]. Oncogene,2001, 20(40): 5623-5637.
  • 9Drakos E,Rassidakis GZ, Lai R, et al. Caspase-3 activation in systemic anaplastic large-cell lymphoma[J].Mod Pathol, 2004, 17(1): 109--116.

二级参考文献29

  • 1Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that R eed-Sternberg cells and histiocytic mtlignancies are derived from activated lymphoid cells. Blo
  • 2Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood, 1994, 84:1361-1392.
  • 3Jaffe ES, Harris NL, Diebold J, et al. World health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: a progress report. Am J Clin Pathol, 1999, 111Suppl 1 :S8-S12.
  • 4Kutok JL, Aster JC. Molecular biology of anaplastic lymphoma kinasepositive anaplastic large cell-lymphoma. J Clin Oncol, 2002, 20:3691-3702.
  • 5Pileri S, Bocchia M, Baroni CD, et al. Anaplastic large cell lymphoma (CD30 +/Ki- + ): results of a prospective clinico-pathological study of 69 cases. Br J Haematol, 1994, 86:513-523.
  • 6Wood CS, Hardman DL, Boni R, et al. Lack of the t (2; 5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30 + primary cutaneous lymphoproliferative disorders and Hodgkin's disease. Blood, 1996, 88:1765-1770.
  • 7Herbst H, Anagnostopoulos J, Heinze B, et al. ALK gene products in anaplastic large cell lymphomas and Hodgkin' s disease. Blood, 1995,86: 1694-1700.
  • 8Herbst H, Sander C, Tronnier M, et al. Absence of anaplastic lymphoma kinase (ALK) and Epstein-Barr virus gene products in primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis. Br J Dermatol, 1997, 137:680-686.
  • 9Headington JT, Roth MS, Schnitzer B. Regressing atypical histiocytosis:a review and critical appraisal. Sem Diag Pathol, 1987, 4:28-37.
  • 10Zinzani PL, Martelli M, Magagnoli M, et al. Anaplastic large cell lymphoma Hodgkin's like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy. Blood, 1998, 92:790-794.

共引文献14

同被引文献98

引证文献9

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部